Scarica l'app Stockscreener
539.34
0.81%
-4.61
Dopo l'orario di chiusura:
539.17
-0.17
-0.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Evercore ISI Adjusts Price Target on Thermo Fisher Scientific to $590 From $525, Maintains Outperform Rating - MarketScreener
Thermo Fisher's New R&D Alliance With AstraZeneca May Lift Its Stock - Zacks Investment Research
U.S. Cryo Electron Microscopy Market to Witness Massive Growth - openPR.com
Why Top Investors Are Buying Thermo Fisher Scientific Inc. (TMO) - The Acquirer's Multiple
Thermo Fisher Scientific Hits Day High with 3.5% Surge in Stock Price - Markets Mojo
What Does Thermo Fisher’s Recent 17.6% Surge Mean for Investors in 2025? - simplywall.st
Thyroid Cancer Diagnostics Market Size to Surge USD 5.22 Billion at 5.34% CAGR by 2034 - GlobeNewswire Inc.
How Thermo Fisher Scientific Inc. stock performs in weak economyDay Trade & Expert Approved Trade Ideas - newser.com
Thermo Fisher Launches Next-Gen In-Stream Analyzers for Safer, Smarter Slurry Elemental Analysis - AZoMining
How Thermo Fisher Scientific Inc stock moves in volatile trading sessionsWeekly Market Outlook & Technical Confirmation Trade Alerts - newser.com
Top Companies in Biobanking MarketThermo Fisher Scientific - openPR.com
Thermo Fisher Scientific announces R&D partnership with AstraZeneca BioVentureHub - BioSpectrum Asia
Can Thermo Fisher Scientific Inc. recover in the next quarterMarket Rally & Weekly Stock Performance Updates - newser.com
Jim Cramer on Thermo Fisher: “They Really Got Hurt By COVID” - MSN
Thermo Fisher Scientific Inc. stock rises Friday, outperforms market - MSN
Vaxcyte’s Strategic Moves: Impact on PCVX - StocksToTrade
Why Thermo Fisher (TMO) Stock Is Trading Up Today - TradingView
Vector Purification Market Research, Industry Trends & Global Forecasts, 2035, Profiles of Agilent, BIA Separations, Bio-Rad, BioVision, Cytiva, Merck, Sartorius, Takara Bio, Thermo Fisher ScientificResearchAndMarkets.com - Business Wire
KeyBanc maintains Sector Weight rating on Thermo Fisher stock amid mixed segment performance - Investing.com
Thermo Fisher ups the accuracy on elemental analysis - International Mining
Cell and Gene Therapy Manufacturing Services Market Trends & - openPR.com
Where is Thermo Fisher Scientific (TMO) Headed According to Analysts? - MSN
DPIIT inks MoU with Thermo Fisher Scientific to aid 500 biotech startups - Medical Buyer
Thermo Fisher Scientific expands neurodegeneration research capabilities with launch of Olink® Target 48 Neurodegeneration panel - News-Medical
Thermo Fisher Scientific announces pricing of senior notes - Medical Buyer
Will Thermo Fisher Scientific Inc. (TN8) stock return to pre crash levelsJuly 2025 Momentum & Reliable Intraday Trade Alerts - newser.com
Will Thermo Fisher Scientific Inc. stock outperform growth indexesQuarterly Earnings Summary & Verified Stock Trade Ideas - newser.com
BenchSci Partners with Thermo Fisher to Enhance R&D Productivity with AI Tools - SynBioBeta
Q&A: Thermo Fisher’s Luke Wilson on hitting 100% dose delivery with patient-centric supply - drugdiscoverytrends.com
Vaxcyte strikes up to $1B deal for fill-finish space at Thermo Fisher's N.C. production facility - Fierce Pharma
November 14th Options Now Available For Thermo Fisher Scientific (TMO) - Nasdaq
Can Thermo Fisher (TMO) Balance Biomanufacturing Expansion and AI Ambitions to Shape Its Long-Term Edge? - Yahoo Finance
Hans Scientific invests $2B in US to avoid tariffs; Thermo Fisher inks up to $1B contract - Endpoints News
Vaxcyte teams up with Thermo Fisher to ensure future vaccine production - MSN
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday October 22 2025 - MarketScreener
Barclays Adjusts Price Target on Thermo Fisher Scientific to $585 From $550, Maintains Overweight Rating - MarketScreener
Thermo Fisher Scientific Insiders Sold US$2.0m Of Shares Suggesting Hesitancy - 富途牛牛
Barclays Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Raises Target Price to $585 - 富途牛牛
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 22, 2025 - BioSpace
Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub - BioSpace
Bernstein Reaffirms Outperform Rating on Thermo Fisher (TMO) After Investor Roadshow - Yahoo Finance
DPIIT, Thermo Fisher Scientific tie up to boost India’s biotech startup ecosystem - Social News XYZ
Thermo Fisher Scientific gibt Forschungskooperation mit AstraZeneca BioVentureHub bekannt - The Joplin Globe
Thermo Fisher Scientific annonce un partenariat de recherche et développement avec l'AstraZeneca BioVentureHub - Enidnews.com
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism - FinancialContent
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher’s Strategic Moves: Surging Ahead? - StocksToTrade
Thermo Fisher (TMO) Stock Trades Up, Here Is Why - Yahoo Finance
Thermo Fisher Scientific Hits Day High with 4.48% Surge in Stock Price - Markets Mojo
Thermo Fisher Scientific Showcases the Thermo Fisher Connect Platform at Lab of the Future Europe - MarketScreener
Thermo Fisher Scientific (TMO) Rises After Completing $2.5 Billi - GuruFocus
Thermo Fisher Scientific (TMO) Rises Amid Positive Market Sentim - GuruFocus
Thermo Fisher Scientific to hold earnings conference call on Wednesday, October 22 - MarketScreener
Leading Scientific Instrument Maker Thermo Fisher Scientific Announces Q3 2025 Earnings Date and Conference Call - Stock Titan
Bernstein reiterates Outperform rating on Thermo Fisher stock By Investing.com - Investing.com UK
GCC Liquid Biopsy Market Forecast and Company Analysis - GlobeNewswire
Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown - Sahm
Thermo Fisher Scientific Prices $2.5 Billion Worth of Debt Offerings - MarketScreener
1.46%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):